Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

VJVirtual | Bendamustine with dexamethasone in R/R systemic AL amyloidosis

Raymond Comenzo • 20 Jul 2020
Amyloidosis Rare Diseases Antibodies Bendamustine Daratumumab Dexamethasone Ixazomib Lenalidomide Melphalan Prednisone

Raymond Comenzo MD, of Tufts University School of Medicine, Boston, MA, outlines the use of bendamustine with dexamethasone, as an alternative, well-tolerated therapy in relapsed/refractory (R/R) systemic light-chain (AL) amyloidosis. This interview was recorded via an online conference call with the Video Journal of Hematological Oncology (VJHemOnc).

More from Raymond Comenzo

Main results from the ANDROMEDA study 2:54
Main results from the ANDROMEDA study
Raymond Comenzo • 1 Jun 2020
Dual antibody therapy in patients with systemic AL amyloidosis and cardiac involvement 5:23
Dual antibody therapy in patients with systemic AL amyloidosis and cardiac involvement
Raymond Comenzo • 1 Jun 2020
Amyloidosis: diagnosis and stem cell transplantation 13:14
Amyloidosis: diagnosis and stem cell transplantation
Morie Gertz et al. • 14 Sep 2019
How will novel agents affect the amyloidosis population? 12:03
How will novel agents affect the amyloidosis population?
Morie Gertz et al. • 14 Sep 2019

Related Videos

Refining the diagnosis and classification of CMML 6:25
Refining the diagnosis and classification of CMML
Guillermo Montalban-Bravo et al. • 20 Sep 2025
Improving the diagnosis of amyloidosis: advice that can be applied in practice 2:48
Improving the diagnosis of amyloidosis: advice that can be applied in practice
Gareth Morgan • 18 Sep 2025
Ongoing research in gray zone lymphoma 1:07
Ongoing research in gray zone lymphoma
Kieron Dunleavy • 4 Sep 2025
Insights into gray zone lymphoma: a rare subtype of NHL 1:14
Insights into gray zone lymphoma: a rare subtype of NHL
Kieron Dunleavy • 4 Sep 2025
The content of VJHemOnc is intended for healthcare professionals